Table 2.
Prognostic factors associated with survival in lymphoma series
| Ref. | Details on study cohort | Univariate analysis for predictors of death | Multivariate analysis for predictors of death |
| Regalado-Artamendi et al[40], 2021 | Lymphoma patients | Age ≥ 70 yr | Age ≥ 70 yr |
| Comorbidities | Comorbidities | ||
| CURB65 ≥ 3 | CURB ≥ 2 | ||
| Low platelet count | Active disease | ||
| Low hemoglobin level | |||
| High D-dimer | |||
| C-reactive protein >10 mg/dL | |||
| LDH > 300 U/L | |||
| Active disease1 (reference to CR) | |||
| DLBCL histology (reference to FL) | |||
| High-risk lymphoma2 (reference to low risk) | |||
| Lamure et al[39], 2020 | Hospitalized lymphoma patients | Age ≥ 70 yr | Age ≥ 70 yr |
| Hypertension | Active disease | ||
| Previous cancer | |||
| Bendamustine treatment | |||
| Active disease |
1
Partial response or progression.
2
High risk according to prognostic index at diagnosis. CR: Complete response; CURB65: Confusion, urea concentration, respiratory rate, blood pressure and age > 65; DLBCL: Diffuse large B cell lymphoma; FL: Follicular lymphoma; LDH: Lactate dehydrogenase.